Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | EDNRB | P24530 | 4/20 | 0.31 |
| ▸ | EDNRA | P25101 | 4/20 | 0.31 |
| ▸ | MMP2 | P08253 | 3/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23913694 | 0.82 | ALDH1A1 (0.40) | ALDH1A1MAPK1FFAR4TACR1LMNA | |
| SCHEMBL23914033 | 0.78 | ALDH1A1 (0.43) | ALDH1A1MAPK1TSHRTDP1EDNRB | |
| SCHEMBL23913535 | 0.77 | ALDH1A1 (0.33) | ALDH1A1MMP2 | |
| SCHEMBL3253436 | 0.73 | HTR6 (0.47) | ALDH1A1LMNATSHRALOX12ACHE | |
| SCHEMBL14905860 | 0.72 | ACHE (0.50) | ALDH1A1LMNATSHRALOX12ACHE | |
| SCHEMBL26013331 | 0.72 | ACHE (0.50) | ALDH1A1LMNATSHRALOX12ACHE | |
| Bromobenzene SCHEMBL9227147 | 0.72 | ALDH1A1 (0.58) | ALDH1A1MAPK1TACR1LMNATSHR | |
| SCHEMBL2465936 | 0.71 | PTGS2 (0.35) | ALDH1A1MAPK1 | |
| SCHEMBL30253215 | 0.71 | PTGS2 (0.35) | ALDH1A1MAPK1 | |
| SCHEMBL21794128 | 0.68 | CYTH2 (0.51) | ALDH1A1FFAR4LMNATSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317147-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | LG CHEM, LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317147-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CYP1A1, CRY1, CYP1B1 | ALDH1A1 23/4885MAPK1 813/4885FFAR4 4146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.